Artificial Intelligence
How Bayer Plans to Use AI for Key Decisions During Commercialization of Pipeline Assets
Join Dr. Kelkar for an interactive and compelling look into how Bayer is planning on redefining the integration of AI in pharmaceutical intelligence, ensuring strategic and timely decision-making.
